News

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

Hub signal

Search-friendly coverage

Keep the current route structure, but present it with the same premium hierarchy as the homepage.

Explore

Search-friendly hub pages

Regulators

Regulatory Updates

FDA, EMA, PMDA, MHRA, and global regulatory coverage in one crawlable hub.

Open hub

Trials

Clinical Trial Watch

Phase readouts, trial design updates, enrollment milestones, and study results.

Open hub

Pipeline

Drug Pipeline

Regulatory pipeline signals, approvals, and market-moving development updates.

Open hub

Live pharma index

Full coverage

Every signal, indexed and searchable

Browse the complete catalog across approvals, trials, research, devices, and deals - refreshed twice a day.

350+

trusted sources

8k+

indexed stories

daily refresh

Coverage

Latest indexed stories

8,942 stories indexed, page 98 of 150

🌍Apr 25, 2022Industryonkuretherapeutics.com

Featured signal

OnKure Therapeutics Expands Boulder Footprint with the Opening of a New Research Laboratory

Publisher

OnKure Therapeutics

Limited excerpt on-platform. Click anywhere on this card to open the original publisher in a new tab.

OnKure TherapeuticsOriginal publisher link

Canonical metadata stays public, while full text remains on the original site.

🇬🇧Apr 21, 2022Industrygenialcompliance.com

Top 10 Most Common Risks of Homegrown Document Control & Compliance Solutions - Genial

Genial Genetics (Pathozoom AI)Original source

🌍Apr 13, 2022Industrycerbios.swiss

Cerbios announces the near finalization of a new cGMP unit for cytotoxic, a further step towards HPAPIs and ADCs market needs

Cerbios-Pharma SAOriginal source

🌍Apr 9, 2022Industryonkuretherapeutics.com

OnKure Therapeutics Announces Promising Preclinical Data on OKI-179 in RAS-Mutated Tumor Models Presented in a Late-Breaking Session at AACR

OnKure TherapeuticsOriginal source

🇨🇦Apr 6, 2022Researchucalgary.ca

CMF FILMMAKER IN RESIDENCE 2022

University of CalgaryOriginal source

🇺🇸Mar 30, 2022Industrysirnaomics.com

RNAimmune Secures $27 Million Series A Round of Financing for Development of mRNA Therapeutics and Vaccines | Sirnaomics

SirnaomicsOriginal source

🌍Mar 23, 2022Industryomniab.com

Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II

OmniAbOriginal source

🇩🇰Mar 18, 2022Industryserviersymphogen.com

Scientist for In Vivo Pharmacology

SymphogenOriginal source

🌍Mar 18, 2022Mediaphillipsmedisize.com

Drug Delivery Evolution Drives Complexity in Quality Control

Phillips MedisizeOriginal source

🌍Mar 16, 2022Industryan2therapeutics.com

AN2 Therapeutics Appoints Dr. Mel Spigelman, M.D. to its Board of Directors

AN2 TherapeuticsOriginal source

🇺🇸Mar 15, 2022Industrysirnaomics.com

Sirnaomics to Present Latest Developments on its GalNAc-Based Liver-Targeting Platforms and Product Pipeline at the 2022 Oligonucleotide & Precision Therapeutics Congress

SirnaomicsOriginal source

🇺🇸Mar 12, 2022Industrydyne-tx.com

rare disease day video presentation

Dyne TherapeuticsOriginal source

🌍Mar 9, 2022Industryonkuretherapeutics.com

OnKure Therapeutics to Present Late-Breaking Preclinical Data on OKI-179 at the AACR Annual Meeting 2022

OnKure TherapeuticsOriginal source

🇺🇸Mar 8, 2022CDMOnoramco.com

Noramco Celebrates Diversity and International Women’s Day

NoramcoOriginal source

🌍Mar 4, 2022Researchhelsinki.fi

Ukrainan sota - yliopiston suositukset

Helsinki University ResearchOriginal source

🇬🇧Mar 3, 2022Industrygenialcompliance.com

Genial and Cirdan to offer a genomics enabled LIS solution to healthcare customers globally - Genial

Genial Genetics (Pathozoom AI)Original source

🌍Feb 16, 2022Industryan2therapeutics.com

AN2 Therapeutics Announces Epetraborole Granted Orphan Drug Designation in the U.S. for the Treatment of Infections Caused by Non-Tuberculous Mycobacteria

AN2 TherapeuticsOriginal source

🌍Feb 10, 2022Industryan2therapeutics.com

AN2 Therapeutics Reports Phase 1b Data for Oral Epetraborole

AN2 TherapeuticsOriginal source

🌍Feb 8, 2022Industryonkuretherapeutics.com

OnKure Therapeutics Appoints Jason Leverone, CPA, as Chief Financial Officer

OnKure TherapeuticsOriginal source

🇧🇪Feb 5, 2022Industryucb.com

Disposals of own shares

UCB PharmaOriginal source

🇧🇪Feb 4, 2022Industryucb.com

UCB announces positive data in myasthenia gravis with zilucoplan phase 3 study results

UCB PharmaOriginal source

🇧🇪Feb 3, 2022Industryucb.com

Transparency notification FMR LLC.

UCB PharmaOriginal source

🇺🇸Feb 3, 2022Researchforesitecapital.com

Welcoming the Foresite Fellows

Foresite CapitalOriginal source

🇧🇪Feb 2, 2022Industryucb.com

UCB Receives Positive CHMP Opinion Recommending Approval of BRIVIACT[®] (brivaracetam) and VIMPAT[®] (lacosamide) in the EU for Partial-Onset Seizures in Pediatric Patients From Two to Four Years

UCB PharmaOriginal source

🇧🇪Feb 2, 2022Industryucb.com

UCB Commences Tender Offer to Acquire Zogenix, Inc.

UCB PharmaOriginal source

🇧🇪Jan 29, 2022Industryucb.com

Disposals of own shares

UCB PharmaOriginal source

🇧🇪Jan 24, 2022Industryucb.com

BIMZELX[®] (bimekizumab) Approved in Japan for the Treatment of Plaque Psoriasis, Generalized Pustular Psoriasis and Psoriatic Erythroderma

UCB PharmaOriginal source

🇧🇪Jan 22, 2022Industryucb.com

Disposals of own shares

UCB PharmaOriginal source

🇧🇪Jan 21, 2022Industryucb.com

Positive Top-Line Results for BIMZELX[®]▼(bimekizumab) in Second Phase 3 Psoriatic Arthritis Study

UCB PharmaOriginal source

🌍Jan 20, 2022Industryan2therapeutics.com

AN2 Therapeutics Provides Regulatory Update

AN2 TherapeuticsOriginal source

🇧🇪Jan 19, 2022Industryucb.com

UCB to acquire Zogenix

UCB PharmaOriginal source

🌍Jan 18, 2022Industryonkuretherapeutics.com

OnKure Therapeutics Appoints Nicholas A. Saccomano, Ph.D., to its Board of Directors

OnKure TherapeuticsOriginal source

🌍Jan 7, 2022Industryan2therapeutics.com

AN2 Therapeutics Closed $80 Million Series B Financing

AN2 TherapeuticsOriginal source

🇺🇸Dec 30, 2021Industrysirnaomics.com